- Home
- VANI vs HLN Comparison
VANI vs HLN Comparison
Compare VANI & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- HLN
- Stock Information
- Founded
- VANI 1998
- HLN 2022
- Country
- VANI United States
- HLN United Kingdom
- Employees
- VANI N/A
- HLN N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HLN Package Goods/Cosmetics
- Sector
- VANI Health Care
- HLN Consumer Discretionary
- Exchange
- VANI Nasdaq
- HLN Nasdaq
- Market Cap
- VANI 68.1M
- HLN 48.2B
- IPO Year
- VANI 2014
- HLN N/A
- Fundamental
- Price
- VANI $1.26
- HLN $10.25
- Analyst Decision
- VANI Strong Buy
- HLN Buy
- Analyst Count
- VANI 1
- HLN 1
- Target Price
- VANI $4.00
- HLN $10.95
- AVG Volume (30 Days)
- VANI 146.6K
- HLN 14.1M
- Earning Date
- VANI 08-12-2025
- HLN 07-31-2025
- Dividend Yield
- VANI N/A
- HLN 1.73%
- EPS Growth
- VANI N/A
- HLN 38.94
- EPS
- VANI N/A
- HLN 0.20
- Revenue
- VANI N/A
- HLN $14,062,871,660.00
- Revenue This Year
- VANI N/A
- HLN $3.63
- Revenue Next Year
- VANI N/A
- HLN $4.37
- P/E Ratio
- VANI N/A
- HLN $25.66
- Revenue Growth
- VANI N/A
- HLN N/A
- 52 Week Low
- VANI $0.91
- HLN $8.37
- 52 Week High
- VANI $1.50
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- VANI 58.97
- HLN 32.60
- Support Level
- VANI $1.24
- HLN $10.19
- Resistance Level
- VANI $1.33
- HLN $10.61
- Average True Range (ATR)
- VANI 0.06
- HLN 0.12
- MACD
- VANI 0.00
- HLN -0.05
- Stochastic Oscillator
- VANI 59.09
- HLN 8.11
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.